Developer of transformative therapies designed for treating and preventing substance use disorders. The company offers a potent, orally available metabotropic glutamate receptor (mGluR5) negative allo...

Healthcare
Oakland, CA, United States
Founded 2020
8 employees
Website
Valuation
$148M
Market implied
Share Price
N/A
Total Raised
$88.6M
Last Round
N/A

Get the full picture

Create a free account to unlock Tempero Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required